Gutfreund John Peter (CIK 0001940797)

Latest company ownership

Shares held
4,700,157
Last filed at
Jul 3, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 23, 2022 Dec 28, 2022 Insight Molecular Diagnostics Inc. Director Buy 91.3 +75,000 100.00% $24.7K
Aug 15, 2022 Aug 17, 2022 Insight Molecular Diagnostics Inc. Director Buy 91.3 +35,000 100.00% $23.3K